UK pharma policy at a turning point: NICE threshold reform, VPAG, and global trade signals The ICER threshold increase is expected to allow an additional three to five medicines or indications each year to be recommended for NHS use.

#pharma #NICEthresholdreform #NICE #VPAG #ICERthreshold #VPAGnegotiations #MostFavouredNation #NICEappraisals #NHSadoption #HTAs #PatientAccessSchemes #PASdiscounts #NICEseveritymodifier #ABPI #VPAGagreement #PASstrategies #MarketAccesssolutions #HEORevidence #HTAapprovals
zurl.co/O9uRv

Blood cancer patients face treatment access disparity - PharmaTimes New research highlights NHS approval gap compared to other cancers

#healthinequalities #Bloodcancer #Bloodcancerpatients #Bloodcancertreatment #BloodCancerAlliance #bloodcancertreatments #NICEapproval #pharmaceuticalcompanies #NICEappraisals #patientoutcomes #CARTtherapy #CiltaCel #myeloma #NICEappraisalprocesses #patientaccess
pharmatimes.com/news/blood-c...

NICE has made six times more lung cancer treatment recomendations over the past ten years than in the previous decade Sixfold increase in NICE's lung cancer treatment recommendations over the past decade. NICE has recommended osimertinib for routine use on the NHS today.

#oncology #lungcancer #NICEpositiverecommendations #lungcancerpatients #ThoracicOncology #NICElungcancerguidelines #CancerDrugsFund #CDF #NICEappraisals #lungcancerguidelines #lungcancerpatients #lunghealthchecks #lungcancerscreeningprogramme #clinicaltrials
www.nice.org.uk/news/article...